These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 30947025)
1. Vision loss after chemotherapy: an irinotecan-induced retinopathy. Boilève A; Jozwiak M; Malka D; Boige V; Le Roy F; Paques M; Ducreux M Eur J Cancer; 2019 May; 112():80-82. PubMed ID: 30947025 [No Abstract] [Full Text] [Related]
2. Genetics and adverse events with irinotecan treatment: what do we know? Páez D Pharmacogenomics; 2019 Apr; 20(6):393-395. PubMed ID: 31117929 [No Abstract] [Full Text] [Related]
3. Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer. Merrouche Y; Mugneret F; Cahn JY Ann Oncol; 2006 Jun; 17(6):1025-6. PubMed ID: 16293675 [No Abstract] [Full Text] [Related]
4. High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy. Yamada Y; Fujii H; Ohata K; Kato-Hayashi H; Watanabe D; Ishihara T; Uemura S; Iwashita T; Imai H; Matsuhashi N; Takahashi T; Sugiyama T; Shimizu M; Yoshida K; Suzuki A Med Oncol; 2019 Jun; 36(7):63. PubMed ID: 31161433 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer. Murakami S; Saito H; Kondo T; Ito H; Oshita F; Yamada K Cancer Chemother Pharmacol; 2018 Jan; 81(1):81-87. PubMed ID: 29116379 [TBL] [Abstract][Full Text] [Related]
12. RETINOPATHY DURING CHLOROQUINE THERAPY. Wilson W Br J Ophthalmol; 1961 Nov; 45(11):756-8. PubMed ID: 18170732 [No Abstract] [Full Text] [Related]
13. Delayed onset chloroquine retinopathy: case report. Martin LJ; Bergen RL; Dobrow HR Ann Ophthalmol; 1978 Jun; 10(6):723-6. PubMed ID: 677653 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen retinopathy: a rare but serious complication. Bentley CR; Davies G; Aclimandos WA BMJ; 1992 Feb; 304(6825):495-6. PubMed ID: 1312376 [No Abstract] [Full Text] [Related]
15. Paraneoplastic optic neuropathy and retinopathy associated with colon adenocarcinoma. Chao D; Chen WC; Thirkill CE; Lee AG Can J Ophthalmol; 2013 Oct; 48(5):e116-20. PubMed ID: 24093201 [No Abstract] [Full Text] [Related]
16. Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer. Miaris N; Sgouros J; Gerolympou M; Spyropoulos B; Drakopoulos D; Gkoura S; Res H; Samantas E J Gastrointest Cancer; 2019 Mar; 50(1):123-126. PubMed ID: 28660523 [No Abstract] [Full Text] [Related]
17. On the probable association of adalimumab and diffuse retinopathy in a patient with Crohn's disease. Katsanos A; Asproudis I; Katsanos K; Tsianos EV J Crohns Colitis; 2013 Feb; 7(1):e22. PubMed ID: 22784948 [No Abstract] [Full Text] [Related]
18. Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine: a molecular case report. Inoue Y; Miki C; Watanabe H; Hiro J; Toiyama Y; Ojima E; Nakatani K; Nobori T; Kusunoki M Oncol Rep; 2006 Nov; 16(5):971-4. PubMed ID: 17016579 [TBL] [Abstract][Full Text] [Related]
19. [The risk of adverse events of CPT- 11]. Imataka H; Sekikawa T; Ichikawa W Nihon Rinsho; 2016 Nov; 74(11):1847-1851. PubMed ID: 30550693 [TBL] [Abstract][Full Text] [Related]